Mianus Clarity Fund is a "specialist" venture capital fund focused on early-stage investment in global ophthalmology.
Mission Statement:
Our mission is to make early-stage investment in ophthalmology to drive innovation while delivering exceptional returns for our investors.
We also want to make a profound social impact by supporting initiatives that address unmet medical needs, affordability, and inclusivity in eye care. We are dedicated to contributing to a world where everyone has the opportunity to see a brighter future.
Unique Business Model:
We are not just another biotech VC!
We leverage our collaborating CRO (www.meritcro.com ) company’s unparalleled expertise and resource in clinical research to do venture investing. Our CRO provides technology and service for clinical trials across ophthalmology, oncology and respiratory. It is an "insider" in the drug development ecosystem and a global category leader in ophthalmology.
Our investment approach leverages our ecosystem insight and deep access to our scientific advisors to invest in groundbreaking technologies and visionary entrepreneurs. This CRO+VC approach differentiates us.
Company Details
- Founded
- -
- Address
- Unmet Medical Needs
- Industry
- Venture Capital And Private Equity Principals
- NAICS
-
Miscellaneous Intermediation
- Keywords
- ophthalmology and venture capital.
Mianus Clarity Fund Questions
Mianus Clarity Fund's website is https://mianuscapital.com/venture-fund/
Mianus Clarity Fund's LinkedIn profile is https://www.linkedin.com/company/mianus-clarity-fund
Mianus Clarity Fund's industry is
Venture Capital and Private Equity Principals
Mianus Clarity Fund's top competitors are
Vision Catalyst Fund,
All May See Foundation,
Fight For Sight,
Thor Life Science Consulting Ab,
Sophia Innovation Capital,
Vinci Pharmaceuticals, Inc.,
Mianus Capital,
Ren Bioscience,
Merit Cro,
Israel Healthcare Ventures (Ihcv).
Mianus Clarity Fund's categories are Venture Capital and Private Equity Principals
Mianus Clarity Fund's founding year is 2023
